SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
13-Sep-24 4:23 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 12-Sep-24 | Payment of Exercise | 1,486 | $56.15 | $83,438.90 | (3%) 51.55K to 50.06K | |
01-Mar-24 4:59 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 29-Feb-24 | Payment of Exercise | 1,173 | $67.67 | $79,376.90 | (2%) 52.72K to 51.55K | |
16-Feb-24 4:30 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 14-Feb-24 | Grant | 20,131 | -- | -- | 62% 32.59K to 52.72K | |
16-Nov-23 6:13 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 15-Nov-23 | Private Sale | 2,622 | $53.81 | $141,090.00 | (7%) 35.21K to 32.59K | |
14-Sep-23 8:01 AM View: | BioSante Pharmaceuticals, I... (ANIP) | 12-Sep-23 | Payment of Exercise | 1,486 | $61.91 | $91,998.30 | (4%) 36.7K to 35.21K | |
04-Apr-23 8:01 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 28-Feb-23 | Grant | 20,262 | -- | -- | 123% 16.43K to 36.7K | |
14-Sep-22 7:06 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 12-Sep-22 | Grant | 16,433 | -- | -- | 100% 0 to 16.43K |